Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

MeSH terms

• Aging
• Alzheimer Disease / drug therapy*
• Alzheimer Disease / physiopathology
• Amyloid beta-Peptides / antagonists & inhibitors
• Amyloid beta-Peptides / metabolism
• Animals
• Antioxidants / pharmacology
• Brain / drug effects*
• Brain / physiopathology
• Caloric Restriction
• Clinical Trials as Topic
• Glycation End Products, Advanced / metabolism
• Humans
• Nerve Degeneration / prevention & control
• Oxidative Stress
• Reactive Oxygen Species / metabolism
• Resveratrol / pharmacology*
• Sirtuins / metabolism